Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION
Financial strength (30%)
63/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$44.1M
Total Revenue
$45.9M
Total Expenses
$3.1M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
84.7%
Fundraising Efficiency
23468.0%
Operating Reserve
0.82x
Liability-to-Asset
17.5%
Revenue Diversification
96.5%
Executive Compensation
$691K
Compared with Peers
FY 2025
Compared with 105 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
84.7% | 85.4% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
1.9% | 11.1% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
13.4% | 1.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
23468.0% | 368.9% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.8 mo | 10.0 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
17.5% | 23.0% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.5% | 92.0% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-16.8% | 7.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-15.5% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-4.2% | 3.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $44.1M | $45.9M | $3.1M | 84.7% | 0 |
| 2024 | $52.9M | $54.3M | $4.8M | 88.5% | 0 |
| 2023 | $19.0M | $20.9M | $6.2M | 74.4% | 0 |
| 2022 | $30.0M | $30.2M | $7.7M | 85.7% | 0 |
| 2021 | $44.0M | $43.9M | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.